13F HOLDINGS REPORT
BML Capital Management, LLC
Quarter ended Q1 2025 · Filed May 7, 2025 · Accession 0001754960-25-000280
Total Value
$123.6M
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ATEA PHARMACEUTICALS INC | AVIR | 7,609,812 | $22.8M | 18.41% |
| 2 | ACLARIS THERAPEUTICS INC | ACRS | 14,250,000 | $21.8M | 17.65% |
| 3 | THIRD HARMONIC BIO INC | 88427A107 | 3,824,417 | $13.3M | 10.74% |
| 4 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 2,742,317 | $12.0M | 9.70% |
| 5 | AN2 THERAPEUTICS INC | ANTX | 5,749,432 | $7.8M | 6.33% |
| 6 | INSTIL BIO INC | TIL | 416,720 | $7.2M | 5.85% |
| 7 | ESSA PHARMA INC | 29668H708 | 4,221,546 | $6.7M | 5.40% |
| 8 | ORAMED PHARMACEUTICALS INC | ORMP | 3,020,748 | $6.5M | 5.23% |
| 9 | IKENA ONCOLOGY INC | 45175G108 | 3,710,803 | $4.7M | 3.84% |
| 10 | PMV PHARMACEUTICALS INC | PMVP | 3,747,612 | $4.1M | 3.31% |
| 11 | WHITEHAWK THERAPEUTICS INC | WHWK | 1,890,245 | $3.4M | 2.72% |
| 12 | LAVA THERAPEUTICS NV | N51517105 | 1,960,610 | $2.5M | 2.02% |
| 13 | KEZAR LIFE SCIENCES INC | KZR | 408,138 | $2.0M | 1.61% |
| 14 | ELEVATION ONCOLOGY INC | 28623U101 | 5,890,934 | $1.5M | 1.24% |
| 15 | ASTROTECH CORP | ASTC | 220,410 | $1.4M | 1.16% |
| 16 | CONNECT BIOPHARMA HLDGS LTD | CNTB | 2,093,232 | $1.2M | 0.93% |
| 17 | SAGE THERAPEUTICS INC | 78667J108 | 135,095 | $1.1M | 0.87% |
| 18 | ATHIRA PHARMA INC | 04746L104 | 3,200,667 | $911,870 | 0.74% |
| 19 | MILESTONE PHARMACEUTICALS IN | MIST | 1,136,091 | $908,986 | 0.74% |
| 20 | LISATA THERAPEUTICS INC | LSTA | 216,853 | $509,605 | 0.41% |
| 21 | TURNSTONE BIOLOGICS CORP | 90042W100 | 1,103,386 | $452,388 | 0.37% |
| 22 | VISTAGEN THERAPEUTICS INC | VTGN | 150,000 | $375,000 | 0.30% |
| 23 | ALUMIS INC | ALMS | 49,627 | $304,710 | 0.25% |
| 24 | NEXTCURE INC | NXTC | 273,536 | $131,379 | 0.11% |
| 25 | VERRICA PHARMACEUTICALS INC | VRCA | 174,651 | $77,231 | 0.06% |
| 26 | HILLEVAX INC | 43157M102 | 20,760 | $30,102 | 0.02% |
| 27 | ACHILLES THERAPEUTICS PLC | 00449L102 | 3,804,921 | $0 | 0.00% |